Exhibit 99.1 Ocugen Provides Business Update with First Quarter 2024 Financial Results Conference Call and Webcast Today at 8:30 a.m. ET MALVERN, Pa., May 14, 2024 (GLOBE NEWSWIRE) – Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today reported first quarter 2024 financial results along with a general business update. "We've experienced several important clinical and regulatory ...